SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001178913-18-000509
Filing Date
2018-02-13
Accepted
2018-02-13 12:38:12
Documents
1
Group Members
MOSHE ARKINSPHERA GLOBAL HEALTHCARE GP LTD.SPHERA GLOBAL HEALTHCARE MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A zk1821196.htm SC 13G/A 112884
  Complete submission text file 0001178913-18-000509.txt   114672
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Subject) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88182 | Film No.: 18601340
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21 HA'ARBA'AH STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'AH STREET TEL AVIV L3 64739 972-3-6845535
SPHERA FUNDS MANAGEMENT LTD. (Filed by) CIK: 0001496201 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: SC 13G/A